3 - Webinars Archives

Webinars

Smarter Confidence Intervals in Multicenter Trials: The BSVI Advantage

October 12th, 2026 2 minute read

Confidence intervals are an important component of clinical trial reporting, supporting the accurate and reliable int...

Webinars

Regulatory Expectations: Bayesian Guidance from the FDA, CDE, and EMA

September 28th, 2026 2 minute read

Bayesian methods are increasingly being considered to support dose optimization, extrapolation, and adaptive designs ...

Webinars

AI for Clinical Research Series – Prediction

June 26th, 2026 1 minute read

Augmenting Clinical Trials with Synthetic or Simulated Patients, Projecting Long-Term Benefit-Risk, and Developing Re...

Webinars

A Systematic Review into the Use of Bayesian Methods in Clinical Trials

June 25th, 2026 2 minute read

Bayesian methods continue to gain momentum as an alternative approach to traditional clinical trial design, yet many ...

Webinars

AI for Automation and Digital Data Flow

June 24th, 2026 1 minute read

Automate Programming and QC Processes, Accelerating Operations and Evidence Generation This session will explore AI’s...

Webinars

Bridging the Efficacy-Effectiveness Gap in Rare Diseases

June 18th, 2026 1 minute read

Drug development in rare diseases requires the most efficient use of limited data, across both clinical trials and re...

Webinars

Identifying the Best Populations to Target, De-Risking Discovery and Early-Stage Development

June 3rd, 2026 1 minute read

About This Webinar In this session, we explore real-world use cases where AI and LLMs (Large Language Models) have be...

Webinars

Causal Inference Through a Regulatory Lens

May 15th, 2026 1 minute read

About This Webinar As expectations for robust, real-world evidence continue to grow, understanding how regulators eva...

Webinars

From Data to Decisions: TMLE, Doubly Robust Methods, and Federated Learning

April 13th, 2026 1 minute read

This webinar will cover methods that are crucial to making informed decisions. Specifically, personalized care throug...

Webinars

Causal Inference in Real World Evidence: What is it? Why now?

January 22nd, 2026 1 minute read

Causal inference is increasingly used to generate real-world evidence (RWE), by regulatory&n...

Webinars

Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls

November 20th, 2025 1 minute read

Use of external data to augment clinical trials has been increasingly evaluated and is transforming drug development ...

Webinars

SDTM Workflow Transformation: Faster, Easier and More Reliable

November 14th, 2025 1 minute read

The demand for rapid, cost-effective, and standards-compliant SDTM delivery continues to increase across the biotech ...

Webinars

Early Phase Clinical Trials: Key Considerations for Drug Development Pipelines

October 30th, 2025 1 minute read

The early stages of clinical development are critical, decisions made here can determine the efficiency, cost, and ul...

Webinars

Use of Real-World Data for in-silico Trials and Innovative Designs: Recent Successes and Current Perspectives

October 2nd, 2025 1 minute read

Real-world data (RWD) are transforming clinical research. By supplementing randomized controlled trials (RCTs), RWD c...

Webinars

DMC Best Practices: What Biotechs and Sponsors Should Know

August 5th, 2025 1 minute read

Data Monitoring Committees (DMC) are a critical part of the clinical trial process, independently assessing the safet...

Webinars

Harnessing Bayesian Methods: Tackling Challenges in Rare Disease and Small Population Trials

May 27th, 2025 1 minute read

Sponsors working in rare diseases/running small population studies often have difficulties in demonstrating efficacy ...

Webinars

Leveraging Real-World Evidence: Data Sources, Challenges and Applications in Modern Clinical Trials

April 29th, 2025 1 minute read

Real World Evidence (RWE) plays a critical role across multiple pharma processes, including drug development, regulat...

Webinars

Novel Research in Early Phase Trials: Enhancing Efficiency of Combination Strategies

February 28th, 2025 1 minute read

Early phase trials play a crucial role in drug development, determining the dose to test in later phases. With the ri...

Webinars

Strengthening Causal Inference with Sensitivity Analyses: Using the Bayesian Parametric G-Formula

February 19th, 2025 2 minute read

Understanding causal relationships in real-world data is challenging, particularly in observational studies, where co...

Webinars

Mastering Clinical Trial Outsourcing: FSP Solutions from Industry Experts

November 25th, 2024 2 minute read

In Partnership With PCMG Phastar and PCMG partnered to start 2025 with an insightful fireside chat, sharing their ind...

Webinars

Navigating the Real- World: How to Better Utilize Real-World Evidence

October 29th, 2024 2 minute read

Real World Evidence (RWE) is playing an important role in the drug development process by providing valuable insights...

Webinars

EU HTA: Challenges and Opportunities

September 19th, 2024 1 minute read

With the upcoming introduction of the new EU HTA guidance in January 2025, sponsors in the pharmaceutical, Biotech an...

Webinars

Navigating Project Optimus: Implications for Oncology Drug Development

June 27th, 2024 2 minute read

With the launch of Project Optimus, the FDA is reforming the dose optimization and dose selection paradigm in oncolog...

Webinars

Implementing a Gold Standard FSP Strategic Partnership to Fuel Efficient Drug Development

March 7th, 2024 1 minute read

Complete the form below to watch the webinar Featuring: Moderated by Natalie Fforde, Senior Vice President, Global St...

Webinars

Implementing Additional Medidata Solutions

February 27th, 2024 1 minute read

Slides created by: Carly Baker, Director, Clinical Data Operations, and Kat Fogden, Principal Data Operations Program...

Webinars

The New Drug/Biologics License Applications Review Process. What’s all the Fuss?

January 29th, 2024 1 minute read

Presented by: LaRee Tracy, PhD, and Joshua Baker, PhD Complete the form below to watch the webinar

Webinars

Statistical Insights for Biotech Professionals

December 12th, 2023 1 minute read

Complete the form below to watch the webinar

Webinars

Understanding the Pitfalls of P-values and Hypothesis Tests

December 7th, 2023 1 minute read

Complete the form below to watch the webinar

Webinars

Study Design Considerations for Biotechs

November 30th, 2023 1 minute read

Complete the form below to watch the webinar

Webinars

Use of Expert Prior Elicitation for Clinical Research

November 16th, 2023 2 minute read

About this webinar The application of expert prior elicitation in clinical research serves as an important methodolog...

Webinars

A Four-step Strategy for Handling Missing Outcome Data in Randomised Trials Affected by a Pandemic

December 17th, 2021 1 minute read

Presented by: Professor James Carpenter | MRC Clinical Trials Unit, LSHTM Complete the form below to watch the webinar

Webinars

So, you want to meet the FDA? Preparing for Regulatory Meetings & How Statisticians can Influence these Interactions

November 19th, 2020 1 minute read

Presented by: LaRee Tracy, PhD, and Joshua Baker, PhD Complete the form below to watch the webinar

Webinars

The Role of Industry and FDA Statisticians

November 2nd, 2020 1 minute read

Presented by: LaRee Tracy, PhD, and Joshua Baker, PhD Complete the form below to watch the webinar

Webinars

Clearing the Fog: An introduction to LOINC codes

September 18th, 2020 1 minute read

Presented by: Jordan Bristow | Phastar Complete the form below to watch the webinar

Webinars

Blinded by the X-Rays? An Introduction to the Design of Radiotherapy Trials

September 16th, 2020 1 minute read

Presented by: Lucy McParland | Phastar Complete the form below to watch the webinar

Webinars

Data Management’s Role in Multi Stream Data Capture

August 30th, 2020 1 minute read

Presented by: Kirsty Millar | Phastar Complete the form below to watch the webinar

Webinars

Smarter Confidence Intervals in Multicenter Trials: The BSVI Advantage

Regulatory Expectations: Bayesian Guidance from the FDA, CDE, and EMA

AI for Clinical Research Series – Prediction

A Systematic Review into the Use of Bayesian Methods in Clinical Trials

AI for Automation and Digital Data Flow

Bridging the Efficacy-Effectiveness Gap in Rare Diseases

Identifying the Best Populations to Target, De-Risking Discovery and Early-Stage Development

Causal Inference Through a Regulatory Lens

From Data to Decisions: TMLE, Doubly Robust Methods, and Federated Learning

Causal Inference in Real World Evidence: What is it? Why now?

Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls

SDTM Workflow Transformation: Faster, Easier and More Reliable

Early Phase Clinical Trials: Key Considerations for Drug Development Pipelines

Use of Real-World Data for in-silico Trials and Innovative Designs: Recent Successes and Current Perspectives

DMC Best Practices: What Biotechs and Sponsors Should Know

Harnessing Bayesian Methods: Tackling Challenges in Rare Disease and Small Population Trials

Leveraging Real-World Evidence: Data Sources, Challenges and Applications in Modern Clinical Trials

Novel Research in Early Phase Trials: Enhancing Efficiency of Combination Strategies

Strengthening Causal Inference with Sensitivity Analyses: Using the Bayesian Parametric G-Formula

Mastering Clinical Trial Outsourcing: FSP Solutions from Industry Experts

Navigating the Real- World: How to Better Utilize Real-World Evidence

EU HTA: Challenges and Opportunities

Navigating Project Optimus: Implications for Oncology Drug Development

Implementing a Gold Standard FSP Strategic Partnership to Fuel Efficient Drug Development

Implementing Additional Medidata Solutions

The New Drug/Biologics License Applications Review Process. What’s all the Fuss?

Statistical Insights for Biotech Professionals

Understanding the Pitfalls of P-values and Hypothesis Tests

Study Design Considerations for Biotechs

Use of Expert Prior Elicitation for Clinical Research

A Four-step Strategy for Handling Missing Outcome Data in Randomised Trials Affected by a Pandemic

So, you want to meet the FDA? Preparing for Regulatory Meetings & How Statisticians can Influence these Interactions

The Role of Industry and FDA Statisticians

Clearing the Fog: An introduction to LOINC codes

Blinded by the X-Rays? An Introduction to the Design of Radiotherapy Trials

Data Management’s Role in Multi Stream Data Capture

Speak to our Team of Experts